M&A news

Warburg Pincus Acquires Universal NutriScience

Universal NutriScience Pvt Ltd acquired by Warburg Pincus LLC

AcquisitionManufacturingIN

Get the full Universal NutriScience Pvt Ltd company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Universal NutriScience Pvt Ltd logo
Acquired

Universal NutriScience Pvt Ltd

IndiaManufacturing

Undisclosed amount

August 10, 2026

Warburg Pincus LLC logo
Acquirer

Warburg Pincus LLC

Financial Services

Warburg Pincus LLC has acquired Universal NutriScience Pvt Ltd (UNS) for an undisclosed amount. The transaction transfers full ownership of the Mumbai-based nutraceutical company to the global private equity firm, marking its entry into India’s fast-expanding health and wellness segment.

UNS operates as a manufacturer and marketer of nutraceutical and lifestyle products, with a portfolio that includes several pioneering formulations in their respective categories. The company’s operations are closely tied to its sister concern, Universal Medicare, which provides access to advanced research and development laboratories and state-of-the-art manufacturing facilities. Universal Medicare has served as a trusted developer and producer of nutraceuticals in India for over three decades, giving UNS a strong foundation in product quality and supply chain reliability.

For Warburg Pincus, the acquisition aligns with its broader investment strategy in consumer health and preventive care. The firm has been actively deploying capital in sectors with long-term structural growth, and the Indian nutraceutical market fits that profile due to rising health awareness and increasing discretionary spending on wellness products. By acquiring UNS outright, Warburg Pincus gains direct control over a company with established product lines and manufacturing capabilities, rather than taking a minority stake or forming a joint venture.

The deal is expected to accelerate UNS’s product development pipeline, particularly in novel drug delivery systems and new formulations. With fresh capital and strategic oversight, UNS can expand its distribution footprint and introduce additional products under its existing brand umbrella. The company’s access to Universal Medicare’s infrastructure remains intact, which should help maintain continuity in production and quality standards during the transition.

Post-acquisition, UNS is likely to pursue a more aggressive growth trajectory, focusing on scaling its current portfolio while entering new therapeutic and lifestyle categories. Warburg Pincus’s operational expertise in scaling consumer businesses will be central to that effort, though specific product launches or market expansions have not been disclosed. The acquisition positions UNS to compete more directly with larger domestic and multinational players in India’s increasingly crowded wellness market.

No buying signals identified yet.

Unlock GTM signals

Discover Universal NutriScience Pvt Ltd's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Universal NutriScience Pvt Ltd.

Unlock decision-makers